Safety Syringes Market Overview
Over the past decade, there has been a considerable growth in usage of safety syringes over the conventional syringes. Safety syringes consist of an integrated safety that helps to guard healthcare workers against inadvertent needle stick injuries.
Recently, many governments have issued legislation to ensure compulsory use of safety syringes to reduce needlestick injuries and also prevent needle re-use. With the introduction of these legislations, there has been an increased use of safety syringes than conventional syringes in recent times. Further, an increase in the incidence of needle stick injuries, growing injectables market and rising demand for safety mechanisms in syringes are propelling the growth of the global safety syringe market. However, availability of alternate drug delivery methods and a high cost of safety syringes are few factors limiting the growth of the global market. In emerging countries, the safety syringes are being ignored due to lack of awareness about healthcare and safety issues. A rise in government initiative and healthcare and safety awareness could improve adaptability of safety syringes.
Safety Syringes Industry Segment Analysis
The global safety syringes market can be classified on the basis of technology into Retractable and Non-Retractable safety syringes. Further, the retractable syringes market is segmented into Automatic or Manual syringes. And the non-retractable safety syringes are classified as sheathing tube syringes, sliding needle cover syringes, and hinged needle cover syringes. Non-retractable safety syringes account for the largest share of the market while the retractable safety syringes are expected to nurture at a higher CAGR during the forecast period due to growing use in developed nations. On the basis of therapy where the safety syringes are employed, the market is sub-segmented into Insulin, Glucagon-like peptide-1 (GLP-1), Tuberculosis and Growth Hormones therapy syringes. Moreover, taking into account end users, the global safety syringe market is categorized under hospitals and home care.
Safety Syringes Market Forecast Report (2018-2023)
Global Safety Syringes Market is estimated at USD $5.48 Billion in 2018 and is predicted to reach USD $8.42 Billion by 2023, growing at a CAGR of 8.96%.
Safety Syringes Market Regional Outlook
Geographically the global safety syringe market is analyzed under North America, Europe, Asia-Pacific, Latin America & Middle-East and Africa. North America representing the largest share in terms of revenue as well as volume, is witnessing a paradigm shift in usage of safety syringes over traditional syringes. Added to this, the growing demand for prefilled syringes equipped with safety features is also anticipated to drive the market growth in the North American region. In Asia-Pacific, the market is expected to grow due to the ongoing immunization programs supported by the WHO and UNICEF along with increased penetration by the U.S. based companies capitalizing on the growing awareness level regarding the consequences of insecure injection practices.
Major Key Players
Some of the major companies operating in the global safety syringes market
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Technology
5.1.1 Retractable safety syringes
5.1.1.1 Automatic retractable safety syringes
5.1.1.2 Manual retractable safety syringes
5.1.2 Non-Retractable safety syringes
5.1.2.1 Sheathing tube syringes
5.1.2.2 Sliding needle cover syringes
5.1.2.3 Hinged needle cover syringes
5.2 By Therapy
5.2.1 Insulin
5.2.2 Glucagon-like peptide-1 (glp-1)
5.2.3 Tuberculosis
5.2.4 Growth hormones
5.3 By End User
5.3.1 Hospitals
5.3.2 Home Care
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Argentina
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Saudi Arabia
6.5.3 UAE
6.5.4 Qatar
6.5.6 South Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Becton, Dickinson & Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Covidien plc
8.3 Revolutions Medical Corporation
8.4 Retractable Technologies, Inc.
8.5 Smiths Medical
8.6 Unilife Corporation
8.7 Terumo Corporation
8.8 Sol-Millennum
8.9 Ultimed, Inc.
8.10 Axel Bio Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
